Allarity Therapeutics, Inc. Deferred Offering Costs
Allarity Therapeutics, Inc. (ALLR) had Deferred Offering Costs of $3.35 million as of 2023-04-20, per its 10-K filed 2024-03-08.
Discontinued › Balance Sheet › Assets › Assets, Current › Deferred Costs, Current
us-gaap:DeferredOfferingCosts · last filed 2024-03-08
- 2023-04-20: Deferred Offering Costs $3.35M.
- 2023-03-31: Deferred Offering Costs $150.00K.
| Period end | Deferred Offering Costs |
|---|---|
| 2023-04-20 | $3.35M 10-K · filed 2024-03-08 |
| 2023-03-31 | $150.00K 10-Q · filed 2023-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |